Index

A-B-A-C-A design,

39–41, 41

A-B-A design,

38–39, 39, 40

Alcohol, Smoking and Substance Involvement Screening Test,

92

Alcohol Use Disorders Identification Test,

92

Altman Self-Rating Mania Scale,

84

American Psychiatric Association

DSM-5 online assessment measures,

74

mental health performance measures,

74

open-source resources,

74

American Psychological Association, Guidelines for Test User Qualifications,

71

Analysis of variance (ANOVA),

118

Analysis of variance, repeated measures (RM-ANOVA),

119–120

Anxiety, symptom scales for,

81–82

Attention-deficit/hyperactivity disorder (ADHD), symptom scales for,

82–83

Autism, symptom scales for,

83

Autism-Spectrum Quotient Test,

83

Bech-Rafaelsen Mania Scale,

84

Behavioral problems, symptom scales for,

83–84

Behavior and Symptoms Identification System Scale (BASIS; BASIS-24; BASIS-32),

77–78

Better Outcomes Now,

78

Bipolar/mania, symptom scales for,

84–85

Blueprint,

57

Brief Addiction Monitor,

92

Brief Impairment Scale,

91

Brief Problem Checklist,

91

California Psychotherapy Alliance Scales (CALPAS),

93

CARF

.See Commission on Accreditation of Rehabilitation Facilities

CBT

.See Cognitive-behavioral therapy

Center for Epidemiologic Studies Depression Scale (CES-D),

85

Center for Epidemiologic Studies Depression Scale for Children (CES-DC),

86

Center for Quality Assessment and Improvement in Mental Health,

74

Chart Abstracted Measure Specifications Manuals,

75–76

Child Eating Attitudes Test,

87

Child Mania Rating Scale–Parent,

85

Child PTSD Symptom Scale,

89

Children’s Revised Impact of Event Scale,

86

Children’s Yale-Brown Obsessive Compulsive Scale (CY-BOCS),

88

Client Satisfaction Questionnaire (CSQ-18),

93

Clinically Useful Anxiety Outcome Scale (CUXOS),

81

Clinically Useful Depression Outcome Scale (CUDOS),

85

Clinical practice,

127–129.See also Clinician; Therapeutic alliance

Clinician,

126–127.See also Clinical practice; Therapeutic alliance

Code Technology,

57

Cognitive-behavioral therapy (CBT),

24

mission statements comparison,

24–25

progress with,

24

Collective standard protocols,

53–55

Columbia Impairment Scale (CIS),

91

Columbia Suicide Severity Rating Scale (C-SSRS),

92

Commission on Accreditation of Rehabilitation Facilities (CARF),

3, 28

Confidentiality, in testing,

71

Consent, revisions to,

36–37

Copyright

infringement,

69–70

protection of,

70

Cronbach’s a coefficient,

64

Current Procedural Terminology (CPT) codes,

15, 16

Customized individual protocols,

52–53

Daily Living Activities Scale (DLA-20),

90

Data

acquisition,

107

analysis

effect size,

119

regression,

120–121

RM-ANOVA,

119–120

statistics to describe MBC,

116–117, 118

statistics to estimate change,

117–119

calculating,

102–103, 104, 105, 106

cleaning,

106–107

coding,

100, 102, 103

sample dictionary,

103

demographic,

108

item mean substitution,

110–111

legitimacy,

106

Likert-type scaled data,

121

management guidelines,

98–99

missing,

107–113, 109, 112, 113, color plate 4

resources,

113

types of,

108

organizing,

99–100, 101

outliers and erroneous data,

113–115

person mean substitution,

110–111

securing,

115

variables,

108

Depression, symptom scales for,

85–87

Depression Self-Rating Scale for Children,

86

Disruptive Behavior Child and Adolescent Inventory–Parent and Teacher,

83

Disruptive Behavior Disorders Rating Scale,

84

Do-it-yourself (DIY) approach

to building a data bank,

99

to MBC,

23, 30

psychometrics and,

67

Drug Abuse Screening Test (DAST-10),

92

DSM-5 online assessment measures,

74

Duncan, Barry L.,

78

Eating Attitudes Test–26,

87

Eating disorders, symptom scales for,

87

Effect size,

119

Emotion-focused therapy,

25–27, 26

“Emotion schemes,”

24

Empathy Quotient,

83

Evidence-based practice studies,

35, 129–130

Expected mean,

65–66

Fear Questionnaire,

81

Feedback,

8.See also Therapeutic alliance

Frequency, Intensity, Burden of Side Effects Rating Scale,

88

Functional Outcomes Survey–20,

90

Generalized Anxiety Disorder–7 (GAD-7),

81

Glasgow Antipsychotics Side Effect Scale (GASS),

88

Greenspace,

57

Group for the Advancement of Psychiatry,

10

Guidelines for Test User Qualifications,

71

Hamilton Rating Scale for Anxiety (HAM-A),

81

Hamilton Rating Scale for Depression (HAM-D),

44, 85

Health Care Surveys,

75

HIPAA, compliance,

115

Impact of Event Scale–Revised,

89

Institute of Medicine,

61

Inventory of Depressive Symptoms,

85

Item mean substitution,

110–111

Jacobson, Neal,

47

Jain, Saundra,

76

Kennedy Forum,

3, 23

Kessler Psychiatric Distress Scale,

85

Kutcher Adolescent Depression Scale,

87

Lambert, Michael,

47

La Rossa, James,

76

Legal issues, copyright infringement and,

69–70

LibreOffice Calc,

99–100

Liebowitz Social Anxiety Scale,

81

Likert-type scaled data,

121

Liverpool University Neuroleptic Side-Effect Rating Scale,

88

Los Angeles Symptom Checklist,

89

Major Depression Inventory,

86

Measurement-based care (MBC)

.See also Clinician; Therapeutic alliance

application approaches,

52–55

benefits of implementation of,

12

benefits versus barriers to, x

“best practice” and,

129

biases and misconceptions about psychometric measures,

12–19

case-by-case review of,

108–109

codes for reimbursement,

15, 16

commercial platforms,

54, 56, 57, 67

data,

99–115

defining program,

25

definitions of,

4–5

description of,

4

do-it-yourself approach,

23, 30, 67

effects of,

9–10

goals of,

11

integrating into clinical practice,

7–12

iterations of outcomes measurement,

3–4

methodology for clinical practice

A-B-A-C-A design,

39–41, 41

A-B-A design,

38–39, 39, 40

revisions to consent,

36–37

single-subject designs,

37–38

using metrics to substantiate treatment progress,

42–51, 45, 46, 47, 49, color plate 2

misconceptions about outcomes research,

16–17

progress evaluation that indicates failure,

18–19

misconceptions about time and expense,

14–16, 16

online platforms for,

23

overview of operations infrastructure,

35

quality assurance,

97–98

role in practice-based evidence,

129–130

therapeutic alliance and,

8

use in behavioral health and human services, vii

Measure of Mental Health Vital Signs for Private Practices,

78–79

Medication side effects and adherence, symptom scales for,

88

MedWorks Media, Psychiatric Rating Scales,

76

Michener, William,

115

Microsoft Excel,

99–100

conditioning format example,

109, color plate 4

data bank formatting example,

101

data record example,

118

person mean substitution method example,

112

Mindstrong,

57

Mindyra,

57

Mini-Mental State Examination (MMSE),

69–70

Mirah,

57

Missing at random (MAR) data,

108, 110

Missing not at random (MNAR) data,

108, 110

Modified Checklist for Autism in Toddlers,

83

Mood and Feelings Questionnaire–Adolescent,

87

Mood Disorder Questionnaire,

84

Multidimensional Scale of Perceived Social Support (MSPSS),

93

Multitrait Multimethod Matrix (MTMM),

63

Multivariate analysis of variance (MANOVA),

120

MyOutcomes,

57

National Institutes of Health

PROMIS,

74, 75

Roadmap for Medical Research initiative,

75

National Quality Forum,

74

National Quality Measures Clearing House,

74

NeuroFlow,

57

N-O-I-R categories,

100

Obsessive-compulsive disorder (OCD), symptom scales for,

88

“Ockham’s razor,”

67

Ohio Scale for Youth (OSY),

91

Opeeka,

57

Operationalization,

62

choosing measures to match mission,

27

clinical mission into measurable components,

26

cognitive-behavioral therapy,

24

description of,

24

emotion-focused therapy,

25–27, 26

worksheet sample,

131

Outcome Measures Standard CTS 03.01.09,

3, 12, 75–76

Outcome Questionnaire,

47–48

Measure of Mental Health Vital Signs for Private Practices,

78–79

Outcome referrals, The Treatment Outcome Package,

79–80

Owl Insights,

57

Panic Disorder Severity Scale (PDSSSR),

81

Parent Version of the Young Mania Rating Scale (P-YMRS),

85

Partners for Change Outcome Management System, Better Outcomes Now,

78

Patient-centered care,

52, 127–129

Patient Health Questionnaire–9 (PHQ-9),

65–67, 45, 47, 49, 66, 86, 100, 118, color plates 2, 3

Patient-Reported Outcomes Measurement Information System (PROMIS),

74, 75, 103

Anxiety Short-Form Version 1.2,

103, 105, 106

Patients

.See also Therapeutic alliance

insight into MBC,

10

management of data,

36–37

mental health status of,

50–51

noncompliance with MBC,

9

treatment response and remission,

50

Peabody Treatment Progress Battery,

91

Pearson,

18, 71

Pearson’s correlation,

63–64

Pediatric Emotional Distress Scale,

90

Pediatric Symptom Checklist–Youth,

91

Penn State Worry Questionnaire,

81

Penn State Worry Questionnaire for Children,

82

Persistent depressive disorder,

26

Person mean substitution,

110–111, 112

Physicians Consortium for Performance Improvement,

74

Platforms

.See also individual platforms

commercial,

54, 56, 57, 67

online,

23

Posttraumatic stress disorder (PTSD), symptom scales for,

89–90

Post-Traumatic Stress Disorder Checklist–Civilian Version,

89

Practice-based evidence,

129–130

Practice fidelity, ix

Protocols

collective standard,

53–55

comprehensive standard,

55

customized individual,

52–53

Psych Congress Network, Saundra’s Corner,

76

Psychiatric Rating Scales,

76

Psychological testing, misconceptions about,

17–18

Psychology Tools,

76–77

Psychometrically sound scales

.See also individual scales

commercial packages,

77–80

open-access resources,

73–77

overview,

73

psychiatric symptom,

80, 81–93

Psychometric measures

biases and misconceptions about,

12–19, 16

effective reporting,

28–34

Psychometrics

ease of administration,

67

evaluations,

129

Institute of Medicine definition of,

61

measurement error and interpretation,

64–67, 66, color plate 3

normative group data,

64

overview,

61

parsimony,

67

reliability of,

63–64

internal consistency,

63

test-retest reliability,

63–64

validity of,

62–63

concurrent validity,

62–63

confirmatory factor analysis,

63

construct validity,

62

testing,

62–63

Psychometric tests

copyright infringement,

69–70

in the public domain,

69–70

restricted use of,

70–71, 71

Psychotherapy, termination of,

39

Qualification Levels,

18

Qualitative report, sample,

33

Quality assurance (QA),

97–98

Quality of life,

76

symptom scales for,

90–91

Quick Inventory of Depressive Symptomatology,

44, 86

RAND Corporation, Health Care Surveys,

75

Randomized controlled trials,

129–130

Reliable change index (RCI),

45–47, 46, 47, 50, 117–118

Reporting

identifying stakeholders,

28, 29

overview,

28

qualitative reporting,

32–34, 33

tailored stakeholder reporting,

29–32, 31, 32, color plate 1

Revised Children’s Anxiety and Depression Scale Youth,

82

Revised Helping Alliance Questionnaire,

93

Roadmap for Medical Research initiative,

75

Saundra’s Corner,

76

Screen for Child Anxiety Related Emotion Disorders,

82

Self-assessment, bias toward,

12–13

Self-esteem, poor,

26

Self-reporting

response bias,

13–14

symptom scales,

13, 14

Sequenced Treatment Alternatives to Relieve Depression (STAR*D),

40, 44

Short Mood and Feelings Questionnaire,

87

Signal alarm system,

47–48

Single-subject design (SSD)

A-B-A-C-A design,

39–41, 41

A-B-A design,

38–39, 39, 40

interpretation,

41–42, 43

prospective design,

37

repeated measures,

37–38

“Small-N” studies,

37–38

Social anxiety,

26

Social Phobia Inventory,

81

Spence Children’s Anxiety Scale,

82

Stages of Change Scale,

93

Stakeholders

examples of,

31, 32, color plate 1

graphic example,

133

identifying,

28, 29

reporting,

29–32

Standards for Educational and Psychological Testing,

17–18

Strengths and Difficulties Questionnaire,

84

Strengths and Weaknesses of Attention-Deficit/Hyperactivity Symptoms and Normal Behaviors,

82

Substance use, symptom scales for,

92

Suicidality, symptom scales for,

92

Suicide Behaviors Questionnaire–Revised,

92

Swanson Nolan and Pelham questionnaire (SNAP-IV),

82

Systematic Monitoring of Adverse Events Related to Treatments,

88

The Joint Commission (TJC),

28, 127

Chart Abstracted Measure Specifications Manuals,

75–76

mandate for MBC implementation,

12, vii

Therapeutic alliance,

8, 126.See also Clinical practice; Clinician

Total Brain,

57

Trauma History Questionnaire,

89

Trauma History Screen,

89

Treatment

alliance, symptom scales for,

93

effectiveness of,

127

fidelity,

98, 127

progress and satisfaction, symptom scales for,

93

Treatment Outcome Package (TOP),

9, 79–80

Tridiuum,

57

Trochim, William,

62

“True score,”

64–65

University of Rhode Island Change Assessment,

93

Valant,

57

Vanderbilt ADHD Rating Scale,

83

Vista Research Group,

57

Well-adjusted life,

26

“Why-What-How Operationalization Worksheet,”

25, 27

World Health Organization Disability Assessment Schedule 2.0 (WHODAS 2.0),

90

World Health Organization Quality of Life (WHOQOL),

90

Yale-Brown Obsessive Compulsive Scale (Y-BOCS),

88

Youth Mania Rating Scale (YMRS),

84

Youth Top Problems,

84